192 related articles for article (PubMed ID: 16982690)
1. Tyk2 tyrosine kinase expression is required for the maintenance of mitochondrial respiration in primary pro-B lymphocytes.
Potla R; Koeck T; Wegrzyn J; Cherukuri S; Shimoda K; Baker DP; Wolfman J; Planchon SM; Esposito C; Hoit B; Dulak J; Wolfman A; Stuehr D; Larner AC
Mol Cell Biol; 2006 Nov; 26(22):8562-71. PubMed ID: 16982690
[TBL] [Abstract][Full Text] [Related]
2. The Atlantic salmon protein tyrosine kinase Tyk2: molecular cloning, modulation of expression and function.
Sobhkhez M; Hansen T; Iliev DB; Skjesol A; Jørgensen JB
Dev Comp Immunol; 2013 Dec; 41(4):553-63. PubMed ID: 23872231
[TBL] [Abstract][Full Text] [Related]
3. Activation of Tyk2 and Stat3 is required for the apoptotic actions of interferon-beta in primary pro-B cells.
Gamero AM; Potla R; Wegrzyn J; Szelag M; Edling AE; Shimoda K; Link DC; Dulak J; Baker DP; Tanabe Y; Grayson JM; Larner AC
J Biol Chem; 2006 Jun; 281(24):16238-44. PubMed ID: 16601124
[TBL] [Abstract][Full Text] [Related]
4. Regulation of lipopolysaccharide-induced inducible nitric-oxide synthase expression through the nuclear factor-kappaB pathway and interferon-beta/tyrosine kinase 2/Janus tyrosine kinase 2-signal transducer and activator of transcription-1 signaling cascades by 2-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (THI 53), a new synthetic isoquinoline alkaloid.
Kim HJ; Tsoyi K; Heo JM; Kang YJ; Park MK; Lee YS; Lee JH; Seo HG; Yun-Choi HS; Chang KC
J Pharmacol Exp Ther; 2007 Feb; 320(2):782-9. PubMed ID: 17108235
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine kinase 2 interacts with the proapoptotic protein Siva-1 and augments its apoptotic functions.
Shimoda HK; Shide K; Kameda T; Matsunaga T; Shimoda K
Biochem Biophys Res Commun; 2010 Sep; 400(2):252-7. PubMed ID: 20727854
[TBL] [Abstract][Full Text] [Related]
6. Requirement of catalytically active Tyk2 and accessory signals for the induction of TRAIL mRNA by IFN-beta.
Rani MR; Pandalai S; Shrock J; Almasan A; Ransohoff RM
J Interferon Cytokine Res; 2007 Sep; 27(9):767-79. PubMed ID: 17892398
[TBL] [Abstract][Full Text] [Related]
7. Identification of an indispensable role for tyrosine kinase 2 in CTL-mediated tumor surveillance.
Simma O; Zebedin E; Neugebauer N; Schellack C; Pilz A; Chang-Rodriguez S; Lingnau K; Weisz E; Putz EM; Pickl WF; Felzmann T; Müller M; Decker T; Sexl V; Stoiber D
Cancer Res; 2009 Jan; 69(1):203-11. PubMed ID: 19118004
[TBL] [Abstract][Full Text] [Related]
8. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway.
Watling D; Guschin D; Müller M; Silvennoinen O; Witthuhn BA; Quelle FW; Rogers NC; Schindler C; Stark GR; Ihle JN
Nature; 1993 Nov; 366(6451):166-70. PubMed ID: 7901766
[TBL] [Abstract][Full Text] [Related]
9. An important role of Tyk2 in APC function of dendritic cells for priming CD8+ T cells producing IFN-gamma.
Aizu K; Li W; Yajima T; Arai T; Shimoda K; Nimura Y; Yoshikai Y
Eur J Immunol; 2006 Nov; 36(11):3060-70. PubMed ID: 17048270
[TBL] [Abstract][Full Text] [Related]
10. Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock.
Karaghiosoff M; Steinborn R; Kovarik P; Kriegshäuser G; Baccarini M; Donabauer B; Reichart U; Kolbe T; Bogdan C; Leanderson T; Levy D; Decker T; Müller M
Nat Immunol; 2003 May; 4(5):471-7. PubMed ID: 12679810
[TBL] [Abstract][Full Text] [Related]
11. Hapten-induced contact hypersensitivity is enhanced in Tyk2-deficient mice.
Hosogi M; Tonogaito H; Aioi A; Hamada K; Shimoda K; Muromoto R; Matsuda T; Miyachi Y
J Dermatol Sci; 2004 Oct; 36(1):51-6. PubMed ID: 15488705
[TBL] [Abstract][Full Text] [Related]
12. Organ-specific and differential requirement of TYK2 and IFNAR1 for LPS-induced iNOS expression in vivo.
Painz R; Walter I; Kolbe T; Rigler D; Vogl C; Steinborn R; Rülicke T; Helmreich M; Karaghiosoff M; Müller M
Immunobiology; 2007; 212(9-10):863-75. PubMed ID: 18086385
[TBL] [Abstract][Full Text] [Related]
13. Tyk2 is essential for IFN-alpha-induced gene expression in mast cells.
Mori Y; Hirose K; Suzuki K; Nakajima H; Seto Y; Ikeda K; Shimoda K; Nakayama K; Saito Y; Iwamoto I
Int Arch Allergy Immunol; 2004 Jun; 134 Suppl 1():25-9. PubMed ID: 15166480
[TBL] [Abstract][Full Text] [Related]
14. TYK2 kinase activity is required for functional type I interferon responses in vivo.
Prchal-Murphy M; Semper C; Lassnig C; Wallner B; Gausterer C; Teppner-Klymiuk I; Kobolak J; Müller S; Kolbe T; Karaghiosoff M; Dinnyés A; Rülicke T; Leitner NR; Strobl B; Müller M
PLoS One; 2012; 7(6):e39141. PubMed ID: 22723949
[TBL] [Abstract][Full Text] [Related]
15. Myxoma virus selectively disrupts type I interferon signaling in primary human fibroblasts by blocking the activation of the Janus kinase Tyk2.
Wang F; Barrett JW; Shao Q; Gao X; Dekaban GA; McFadden G
Virology; 2009 Apr; 387(1):136-46. PubMed ID: 19254804
[TBL] [Abstract][Full Text] [Related]
16. Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competent.
Li Z; Gakovic M; Ragimbeau J; Eloranta ML; Rönnblom L; Michel F; Pellegrini S
J Immunol; 2013 Mar; 190(5):2335-44. PubMed ID: 23359498
[TBL] [Abstract][Full Text] [Related]
17. A mutant form of p135tyk2, an interferon-alpha inducible tyrosine kinase, suppresses the transformed phenotype of Daudi cells.
Davis E; Krishnan K; Yan H; Newcomb EW; Krolewski JJ
Leukemia; 1996 Mar; 10(3):543-51. PubMed ID: 8642873
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine kinase 2 modulates splenic B cells through type I IFN and TLR7 signaling.
Bodega-Mayor I; Delgado-Wicke P; Arrabal A; Alegría-Carrasco E; Nicolao-Gómez A; Jaén-Castaño M; Espadas C; Dopazo A; Martín-Gayo E; Gaspar ML; de Andrés B; Fernández-Ruiz E
Cell Mol Life Sci; 2024 Apr; 81(1):199. PubMed ID: 38683377
[TBL] [Abstract][Full Text] [Related]
19. A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling.
Yeh TC; Dondi E; Uze G; Pellegrini S
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8991-6. PubMed ID: 10908660
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes.
Bright JJ; Sriram S
J Immunol; 1998 Aug; 161(4):1772-7. PubMed ID: 9712043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
